Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Peptides and Peptide Mimetics: Potential Tools for Therapy"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 7215
Special Issue Editor
Special Issue Information
It is a great pleasure to announce the opening of a Topic dedicated to “Peptides and Peptide Mimetics: Potential Tools for Therapy”.
Biomedical research is constantly oriented toward the development of new therapeutics based on peptides. Peptides have been widely investigated across the therapeutic spectrum and successfully developed as drugs, vaccines, and cosmeceuticals, providing treatment for diabetes, endocrine disorders, cancer, Alzheimer’s disease, cardiovascular disease, and many more.
Over the last few decades, the increase in the generation of peptidomimetics, as well as the maturity of peptide synthesis technology, have managed to helpt to overcome the limitations of peptide drugs and highlight their attractive pharmacokinetics profile, including their remarkable potency, selectivity, and low toxicity. Moreover, interest in larger peptidomimetics, such as foldamers and macrocycles, is growing, especially with a view to developing novel antimicrobial therapeutics and to identifying bioactive compounds addressing protein–protein interactions.
In recent years, targeted therapies have aroused growing interest as effective strategies to improve therapeutic efficacy, reduce the impact of adverse side effects, and overcome drug resistance. Peptides and peptide mimetics have proved particularly effective as antimicrobial and anticancer carriers due to targeted drug delivery at the action sites.
Therefore, we invite investigators to contribute original research articles as well as review articles in the following potential topics:
- Biopharmaceutical issues for peptide administration (enzymatic degradation, nonspecific distribution in the body, and physical and chemical instability);
- Chemical modification of the peptides (design, synthesis, analysis);
- Antimicrobial peptides;
- Anticancer peptides;
- Peptides as targeting moieties;
- Molecular modeling.
Dr. Tamara Pajpanova
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biopharmaceutical issues for peptide administration (enzymatic degradation, nonspecific distribution in the body, and physical and chemical instability)
- chemical modification of the peptides (design, synthesis, analysis)
- antimicrobial peptides
- anticancer peptides
- peptides as targeting moieties
- molecular modeling